- $2.63bn
- $2.44bn
- $350.87m
- 75
- 14
- 68
- 51
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 143 | 187 | 215 | 272 | 351 |
Cost of Revenue | |||||
Gross Profit | 98.3 | 116 | 140 | 173 | 239 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 147 | 204 | 238 | 374 | 420 |
Operating Profit | -4.1 | -16.8 | -23 | -102 | -69.3 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -24.9 | -45.6 | -46.3 | -103 | -69.9 |
Provision for Income Taxes | |||||
Net Income After Taxes | -17.1 | -45.9 | -46.8 | -99.7 | -69.4 |
Net Income Before Extraordinary Items | |||||
Net Income | -17.1 | -45.9 | -46.8 | -99.7 | -69.4 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -29.2 | -60 | -62.3 | -99.7 | -69.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.496 | -0.98 | -1.04 | -1.58 | -1.05 |
Dividends per Share |